AI Analysis
AI-generated analysis. Always verify with the original filing.
Novo Nordisk A/S reported transactions under its share repurchase programme initiated 4 February 2026, purchasing 1,270,000 B shares from 16-20 March 2026 for DKK 308,156,081. Cumulative repurchases total 7,847,992 B shares for DKK 2,091,696,255, with treasury holdings at 25,237,791 B shares (0.6% of 4,465,000,000 total shares).
Key Takeaways
1Overall programme: up to DKK 15 billion over 12 months from 4 February 2026.
2Current phase: up to DKK 3.8 billion from 4 February to 4 May 2026.
3Accumulated repurchases as of 20 March 2026: 7,847,992 B shares for DKK 2,091,696,255 at average DKK 266.53.
4Treasury B shares: 25,237,791, equal to 0.6% of share capital.
5Total A and B shares including treasury: 4,465,000,000.